An early-phase clinical trial evaluating ABC294640 in patients with refractory/RE
Ended Cooperative Agreement Awarded Last action
- Award ID
- R42CA183708
- Recipient
-
Apogee Biotechnology Corporation UEI J9Q4KEGSLWY9
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,062,425
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Hummelstown, PA 17036, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$79,126 | |
| Amendment | $133,116 | |
| Amendment | $499,411 | |
| Original award | $509,024 |
Quick answers
Who received award R42CA183708?
R42CA183708 was awarded to Apogee Biotechnology Corporation by National Institutes of Health (Department of Health and Human Services) on September 17, 2014.
How much is award R42CA183708 worth?
$1,062,425 has been obligated on R42CA183708.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award